Your browser doesn't support javascript.
loading
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.
Schoenfeld, Jonathan D; Gjini, Evisa; Rodig, Scott J; Tishler, Roy B; Rawal, Bhupendra; Catalano, Paul J; Uppaluri, Ravindra; Haddad, Robert I; Hanna, Glenn J; Chau, Nicole G; Rabinowits, Guilherme; Lorch, Jochen; Jo, Vickie Y; Krane, Jeffrey F; Goguen, Laura A; Annino, Donald J; Abdelrahman, Sara; Lipschitz, Mikel; Margalit, Danielle N.
Afiliación
  • Schoenfeld JD; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: jonathan_schoenfeld@dfci.harvard.edu.
  • Gjini E; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rodig SJ; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tishler RB; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rawal B; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Catalano PJ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Uppaluri R; Division of Otolaryngology, Department of Surgery, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chau NG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rabinowits G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lorch J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jo VY; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts.
  • Krane JF; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts.
  • Goguen LA; Division of Otolaryngology, Department of Surgery, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Annino DJ; Division of Otolaryngology, Department of Surgery, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Abdelrahman S; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lipschitz M; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Margalit DN; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Int J Radiat Oncol Biol Phys ; 102(1): 137-145, 2018 09 01.
Article en En | MEDLINE | ID: mdl-29960819

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias Orofaríngeas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2018 Tipo del documento: Article